Biovico

CompanyPoland

Biovico develops one asset, in human trials (F-GYN in atrophic vaginitis). Mostly device; based in Poland.

1
Asset
Furthest: Human trials; 1
Trial: 1
Signal

Pipeline

1

F-GYN
Injectable non-crosslinked hyaluronic acid gel providing hydration and restoration of vaginal and vestibular tissue
Human trials, Device, atrophic vaginitis, atrophic vulvovaginitis

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Signals1
Similar companies6

Updated 7 Oct 2026 · 2 sources